LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 91

Search options

  1. Article: A novel Bayesian model for assessing intratumor heterogeneity of tumor infiltrating leukocytes with multi-region gene expression sequencing.

    Yang, Peng / Hubert, Shawna M / Futreal, P Andrew / Song, Xingzhi / Zhang, Jianhua / Lee, J Jack / Wistuba, Ignacio / Yuan, Ying / Zhang, Jianjun / Li, Ziyi

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Intratumor heterogeneity (ITH) of tumor-infiltrated leukocytes (TILs) is an important phenomenon of cancer biology with potentially profound clinical impacts. Multi-region gene expression sequencing data provide a promising opportunity that allows for ... ...

    Abstract Intratumor heterogeneity (ITH) of tumor-infiltrated leukocytes (TILs) is an important phenomenon of cancer biology with potentially profound clinical impacts. Multi-region gene expression sequencing data provide a promising opportunity that allows for explorations of TILs and their intratumor heterogeneity for each subject. Although several existing methods are available to infer the proportions of TILs, considerable methodological gaps exist for evaluating intratumor heterogeneity of TILs with multi-region gene expression data. Here, we develop ICeITH, immune cell estimation reveals intratumor heterogeneity, a Bayesian hierarchical model that borrows cell type profiles as prior knowledge to decompose mixed bulk data while accounting for the within-subject correlations among tumor samples. ICeITH quantifies intratumor heterogeneity by the variability of targeted cellular compositions. Through extensive simulation studies, we demonstrate that ICeITH is more accurate in measuring relative cellular abundance and evaluating intratumor heterogeneity compared with existing methods. We also assess the ability of ICeITH to stratify patients by their intratumor heterogeneity score and associate the estimations with the survival outcomes. Finally, we apply ICeITH to two multi-region gene expression datasets from lung cancer studies to classify patients into different risk groups according to the ITH estimations of targeted TILs that shape either pro- or anti-tumor processes. In conclusion, ICeITH is a useful tool to evaluate intratumor heterogeneity of TILs from multi-region gene expression data.
    Language English
    Publishing date 2023-10-29
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.10.24.563820
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Endothelial-to-osteoblast transition in normal mouse bone development.

    Lin, Song-Chang / Yu, Guoyu / Lee, Yu-Chen / Song, Jian H / Song, Xingzhi / Zhang, Jianhua / Panaretakis, Theocharis / Logothetis, Christopher J / Komatsu, Yoshihiro / Yu-Lee, Li-Yuan / Wang, Guocan / Lin, Sue-Hwa

    iScience

    2023  Volume 26, Issue 2, Page(s) 105994

    Abstract: Metastatic prostate cancer (PCa) in bone induces bone-forming lesions. We have previously shown that PCa-induced bone originates from endothelial cells (ECs) that have undergone EC-to-osteoblast (OSB) transition. Here, we investigated whether EC-to-OSB ... ...

    Abstract Metastatic prostate cancer (PCa) in bone induces bone-forming lesions. We have previously shown that PCa-induced bone originates from endothelial cells (ECs) that have undergone EC-to-osteoblast (OSB) transition. Here, we investigated whether EC-to-OSB transition also occurs during normal bone formation. We developed an EC and OSB dual-color reporter mouse (DRM) model that marks EC-OSB hybrid cells with red and green fluorescent proteins. We observed EC-to-OSB transition (RFP and GFP co-expression) in both endochondral and intramembranous bone formation during embryonic development and in adults. Co-expression was confirmed in cells isolated from DRM. Bone marrow- and lung-derived ECs underwent transition to OSBs and mineralization in osteogenic medium. RNA-sequencing revealed GATA family transcription factors were upregulated in EC-OSB hybrid cells and knockdown of
    Language English
    Publishing date 2023-01-16
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2023.105994
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Tsyn-Seq: a T-cell Synapse-Based Antigen Identification Platform.

    Jin, Yimei / Miyama, Takahiko / Brown, Alexandria / Hayase, Tomo / Song, Xingzhi / Singh, Anand K / Huang, Licai / Flores, Ivonne I / McDaniel, Lauren K / Glover, Israel / Halsey, Taylor M / Prasad, Rishika / Chapa, Valerie / Ahmed, Saira / Zhang, Jianhua / Rai, Kunal / Peterson, Christine B / Lizee, Gregory / Karmouch, Jennifer /
    Hayase, Eiko / Molldrem, Jeffrey J / Chang, Chia-Chi / Tsai, Wen-Bin / Jenq, Robert R

    Cancer immunology research

    2024  Volume 12, Issue 5, Page(s) 530–543

    Abstract: Tools for genome-wide rapid identification of peptide-major histocompatibility complex targets of T-cell receptors (TCR) are not yet universally available. We present a new antigen screening method, the T-synapse (Tsyn) reporter system, which includes ... ...

    Abstract Tools for genome-wide rapid identification of peptide-major histocompatibility complex targets of T-cell receptors (TCR) are not yet universally available. We present a new antigen screening method, the T-synapse (Tsyn) reporter system, which includes antigen-presenting cells (APC) with a Fas-inducible NF-κB reporter and T cells with a nuclear factor of activated T cells (NFAT) reporter. To functionally screen for target antigens from a cDNA library, productively interacting T cell-APC aggregates were detected by dual-reporter activity and enriched by flow sorting followed by antigen identification quantified by deep sequencing (Tsyn-seq). When applied to a previously characterized TCR specific for the E7 antigen derived from human papillomavirus type 16 (HPV16), Tsyn-seq successfully enriched the correct cognate antigen from a cDNA library derived from an HPV16-positive cervical cancer cell line. Tsyn-seq provides a method for rapidly identifying antigens recognized by TCRs of interest from a tumor cDNA library. See related Spotlight by Makani and Joglekar, p. 515.
    MeSH term(s) Humans ; Receptors, Antigen, T-Cell/immunology ; Receptors, Antigen, T-Cell/genetics ; T-Lymphocytes/immunology ; High-Throughput Nucleotide Sequencing ; Papillomavirus E7 Proteins/immunology ; Papillomavirus E7 Proteins/genetics ; Gene Library ; Antigen-Presenting Cells/immunology ; NFATC Transcription Factors/metabolism ; NFATC Transcription Factors/immunology ; Cell Line, Tumor ; NF-kappa B/metabolism ; Immunological Synapses/immunology ; Human papillomavirus 16/immunology ; Human papillomavirus 16/genetics ; Female
    Chemical Substances Receptors, Antigen, T-Cell ; Papillomavirus E7 Proteins ; NFATC Transcription Factors ; oncogene protein E7, Human papillomavirus type 16 ; NF-kappa B
    Language English
    Publishing date 2024-02-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2732489-8
    ISSN 2326-6074 ; 2326-6066
    ISSN (online) 2326-6074
    ISSN 2326-6066
    DOI 10.1158/2326-6066.CIR-23-0467
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment.

    Yu, Guoyu / Corn, Paul G / Mak, Celia Sze Ling / Liang, Xin / Zhang, Miao / Troncoso, Patricia / Song, Jian H / Lin, Song-Chang / Song, Xingzhi / Liu, Jingjing / Zhang, Jianhua / Logothetis, Christopher J / Melancon, Marite P / Panaretakis, Theocharis / Wang, Guocan / Lin, Sue-Hwa

    bioRxiv : the preprint server for biology

    2023  

    Abstract: Immune checkpoint therapy has limited efficacy for patients with bone metastatic castrate-resistant prostate cancer (bmCRPC). In this study, we revealed a novel mechanism that may account for the relative resistance of bmCRPC to immune checkpoint therapy. ...

    Abstract Immune checkpoint therapy has limited efficacy for patients with bone metastatic castrate-resistant prostate cancer (bmCRPC). In this study, we revealed a novel mechanism that may account for the relative resistance of bmCRPC to immune checkpoint therapy. We found that prostate cancer (PCa)-induced bone via endothelial-to-osteoblast (EC-to-OSB) transition causes an ingress of M2-like macrophages, leading to an immunosuppressive bone tumor microenvironment (bone-TME). Analysis of a bmCRPC RNA-seq dataset revealed shorter overall survival in patients with an M2-high versus M2-low signature. Immunohistochemical (IHC) analysis showed CD206
    Significance: The insight that prostate cancer-induced bone generates an immunosuppressive bone tumor microenvironment offers a strategy to improve responses to immunotherapy approaches in patients with bone metastatic castrate-resistant prostate cancer.
    Language English
    Publishing date 2023-12-02
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.11.30.569496
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases.

    Zhao, Shuangtao / Wang, Ruiping / Song, Shumei / Hao, Dapeng / Han, Guangchun / Song, Xingzhi / Zhang, Jianhua / Pizzi, Melissa Pool / Shanbhag, Namita / Futreal, Andrew / Badgwell, Brian / Harada, Kazuto / Calin, George / Vykoukal, Jody / Yu, Chuan-Yih / Katayama, Hiroyuki / Hanash, Samir M / Wang, Linghua / Ajani, Jaffer A

    iScience

    2023  Volume 26, Issue 6, Page(s) 106913

    Abstract: Advanced gastric adenocarcinoma (GAC) often leads to peritoneal carcinomatosis (PC) and is associated with very poor outcome. Here we report the comprehensive proteogenomic study of ascites derived cells from a prospective GAC cohort (n = 26 patients ... ...

    Abstract Advanced gastric adenocarcinoma (GAC) often leads to peritoneal carcinomatosis (PC) and is associated with very poor outcome. Here we report the comprehensive proteogenomic study of ascites derived cells from a prospective GAC cohort (n = 26 patients with peritoneal carcinomatosis, PC). A total of 16,449 proteins were detected from whole cell extracts (TCEs). Unsupervised hierarchical clustering resulted in three distinct groups that reflected extent of enrichment in tumor cells. Integrated analysis revealed enriched biological pathways and notably, some druggable targets (cancer-testis antigens, kinases, and receptors) that could be exploited to develop effective therapies and/or tumor stratifications. Systematic comparison of expression levels of proteins and mRNAs revealed special expression patterns of key therapeutics target notably high mRNA and low protein expression of HAVCR2 (TIM-3), and low mRNA but high protein expression of cancer-testis antigens CTAGE1 and CTNNA2. These results inform strategies to target GAC vulnerabilities.
    Language English
    Publishing date 2023-05-19
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2023.106913
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Feasibility of a novel non-invasive swab technique for serial whole-exome sequencing of cervical tumors during chemoradiation therapy.

    Bronk, Julianna K / Kapadia, Chiraag / Wu, Xiaogang / Chapman, Bhavana V / Wang, Rui / Karpinets, Tatiana V / Song, Xingzhi / Futreal, Andrew M / Zhang, Jianhua / Klopp, Ann H / Colbert, Lauren E

    PloS one

    2022  Volume 17, Issue 10, Page(s) e0274457

    Abstract: Background: Clinically relevant genetic predictors of radiation response for cervical cancer are understudied due to the morbidity of repeat invasive biopsies required to obtain genetic material. Thus, we aimed to demonstrate the feasibility of a novel ... ...

    Abstract Background: Clinically relevant genetic predictors of radiation response for cervical cancer are understudied due to the morbidity of repeat invasive biopsies required to obtain genetic material. Thus, we aimed to demonstrate the feasibility of a novel noninvasive cervical swab technique to (1) collect tumor DNA with adequate throughput to (2) perform whole-exome sequencing (WES) at serial time points over the course of chemoradiation therapy (CRT).
    Methods: Cervical cancer tumor samples from patients undergoing chemoradiation were collected at baseline, at week 1, week 3, and at the completion of CRT (week 5) using a noninvasive swab-based biopsy technique. Swab samples were analyzed with whole-exome sequencing (WES) with mutation calling using a custom pipeline optimized for shallow whole-exome sequencing with low tumor purity (TP). Tumor mutation changes over the course of treatment were profiled.
    Results: 216 samples were collected and successfully sequenced for 70 patients (94% of total number of tumor samples collected). A total of 33 patients had a complete set of samples at all four time points. The mean mapping rate was 98% for all samples, and the mean target coverage was 180. Estimated TP was greater than 5% for all samples. Overall mutation frequency decreased during CRT but mapping rate and mean target coverage remained at >98% and >180 reads at week 5.
    Conclusion: This study demonstrates the feasibility and application of a noninvasive swab-based technique for WES analysis which may be applied to investigate dynamic tumor mutational changes during treatment to identify novel genes which confer radiation resistance.
    MeSH term(s) Exome ; Feasibility Studies ; Female ; High-Throughput Nucleotide Sequencing/methods ; Humans ; Mutation ; Uterine Cervical Neoplasms/genetics ; Uterine Cervical Neoplasms/therapy ; Whole Exome Sequencing
    Language English
    Publishing date 2022-10-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0274457
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Complete loss of

    Beird, Hannah C / Wu, Chia-Chin / Nakazawa, Michael / Ingram, Davis / Daniele, Joseph R / Lazcano, Rossana / Little, Latasha / Davies, Christopher / Daw, Najat C / Wani, Khalida / Wang, Wei-Lien / Song, Xingzhi / Gumbs, Curtis / Zhang, Jianhua / Rubin, Brian / Conley, Anthony / Flanagan, Adrienne M / Lazar, Alexander J / Futreal, P Andrew

    HGG advances

    2023  Volume 4, Issue 4, Page(s) 100224

    Abstract: Rhabdomyosarcoma accounts for roughly 1% of adult sarcomas, with pleomorphic rhabdomyosarcoma (PRMS) as the most common subtype. Survival outcomes remain poor for patients with PRMS, and little is known about the molecular drivers of this disease. To ... ...

    Abstract Rhabdomyosarcoma accounts for roughly 1% of adult sarcomas, with pleomorphic rhabdomyosarcoma (PRMS) as the most common subtype. Survival outcomes remain poor for patients with PRMS, and little is known about the molecular drivers of this disease. To better characterize PRMS, we performed a broad array of genomic and immunostaining analyses on 25 patient samples. In terms of gene expression and methylation, PRMS clustered more closely with other complex karyotype sarcomas than with pediatric alveolar and embryonal rhabdomyosarcoma. Immune infiltrate levels in PRMS were among the highest observed in multiple sarcoma types and contrasted with low levels in other rhabdomyosarcoma subtypes. Lower immune infiltrate was associated with complete loss of both
    MeSH term(s) Adult ; Humans ; Child ; Rhabdomyosarcoma/genetics ; Rhabdomyosarcoma, Embryonal/genetics ; Genomics ; Protein Processing, Post-Translational ; Soft Tissue Neoplasms ; Tumor Suppressor Protein p53/genetics ; Ubiquitin-Protein Ligases ; Retinoblastoma Binding Proteins/genetics
    Chemical Substances TP53 protein, human ; Tumor Suppressor Protein p53 ; RB1 protein, human ; Ubiquitin-Protein Ligases (EC 2.3.2.27) ; Retinoblastoma Binding Proteins
    Language English
    Publishing date 2023-07-19
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ISSN 2666-2477
    ISSN (online) 2666-2477
    DOI 10.1016/j.xhgg.2023.100224
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis.

    Fang, Hong / Beird, Hannah C / Wang, Sa A / Ibrahim, Andrew F / Tang, Zhenya / Tang, Guilin / You, M James / Hu, Shimin / Xu, Jie / Li, Shaoying / Yin, C Cameron / El Hussein, Siba / Le, Nhi / Futreal, P Andrew / Bueso-Ramos, Carlos / Thakral, Beenu / Kadia, Tapan M / Thornton, Rebecca / Little, Latasha /
    Gumbs, Curtis / Song, Xingzhi / Medeiros, L Jeffrey / Wang, Wei

    Leukemia

    2023  Volume 37, Issue 9, Page(s) 1919–1921

    MeSH term(s) Humans ; Leukemia, Prolymphocytic, T-Cell/diagnosis ; Leukemia, Prolymphocytic, T-Cell/genetics ; Leukemia, Prolymphocytic ; Proto-Oncogene Proteins/genetics
    Chemical Substances MTCP1 protein, human ; Proto-Oncogene Proteins
    Language English
    Publishing date 2023-07-13
    Publishing country England
    Document type Letter ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, Non-U.S. Gov't
    ZDB-ID 807030-1
    ISSN 1476-5551 ; 0887-6924
    ISSN (online) 1476-5551
    ISSN 0887-6924
    DOI 10.1038/s41375-023-01956-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Correction: Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets.

    Ferrarotto, Renata / Mitani, Yoshitsugu / McGrail, Daniel J / Li, Kaiyi / Karpinets, Tatiana V / Bell, Diana / Frank, Steven J / Song, Xingzhi / Kupferman, Michael E / Liu, Bin / Lee, J Jack / Glisson, Bonnie S / Zhang, Jianhua / Aster, Jon C / Lin, Shiaw-Yih / Futreal, P Andrew / Heymach, John V / El-Naggar, Adel K

    Clinical cancer research : an official journal of the American Association for Cancer Research

    2023  Volume 29, Issue 14, Page(s) 2737

    Language English
    Publishing date 2023-05-31
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 1225457-5
    ISSN 1557-3265 ; 1078-0432
    ISSN (online) 1557-3265
    ISSN 1078-0432
    DOI 10.1158/1078-0432.CCR-23-1697
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer.

    Aparicio, Ana M / Tidwell, Rebecca S S / Yadav, Shalini S / Chen, Jiun-Sheng / Zhang, Miao / Liu, Jingjing / Guo, Shuai / Pilie, Patrick G / Yu, Yao / Song, Xingzhi / Vundavilli, Haswanth / Jindal, Sonali / Zhu, Keyi / Viscuse, Paul V / Lebenthal, Justin M / Hahn, Andrew W / Soundararajan, Rama / Corn, Paul G / Zurita, Amado J /
    Subudhi, Sumit K / Zhang, Jianhua / Wang, Wenyi / Huff, Chad / Troncoso, Patricia / Allison, James P / Sharma, Padmanee / Logothetis, Christopher J

    Clinical cancer research : an official journal of the American Association for Cancer Research

    2024  

    Abstract: Purpose: To determine the efficacy and safety of risk-adapted combinations of androgen signaling inhibitors and inform disease classifiers for metastatic castration-resistant prostate cancers (mCRPC).: Experimental design: In a modular, randomized ... ...

    Abstract Purpose: To determine the efficacy and safety of risk-adapted combinations of androgen signaling inhibitors and inform disease classifiers for metastatic castration-resistant prostate cancers (mCRPC).
    Experimental design: In a modular, randomized phase II trial, 192 men were treated with 8 weeks of abiraterone acetate, prednisone and apalutamide (AAPA; Module 1), then allocated to Modules 2 or 3 based on Satisfactory (≥50% PSA decline from baseline and <5 CTC/7.5 mL) versus Unsatisfactory status. Men in the former were randomized to continue AAPA alone (Module 2A) or with ipilimumab (Module 2B). Men in the latter had carboplatin+cabazitaxel added to AAPA (Module 3). Optional baseline biopsies were subject to correlative studies.
    Results: Median overall survival (from allocation) was 46.4 (95% CI 39.2, 68.2), 41.4 (95% CI 33.3, 49.9) and 18.7 (95% CI 14.3, 26.3) months in Modules 2A (n=64), 2B (n=64) and 3 (n=59) respectively. Toxicities were within expectations. Of 192 eligible patients, 154 (80.2%) underwent pre-treatment metastatic biopsies. The aggressive variant prostate cancer molecular profile (defects in ≥2 of p53, RB1, and PTEN) was associated with Unsatisfactory status. Exploratory analyses suggested SPP1+ and IGFBP2+ macrophages, druggable myeloid cell markers, and germline pathogenic mutations were enriched in the Unsatisfactory group.
    Conclusions: Adding ipilimumab to AAPA did not improve outcomes in men with androgen responsive mCRPC. Despite the addition of carboplatin+cabazitaxel, men in the Unsatisfactory group had shortened survivals. Adaptive designs can enrich for biologically and clinically relevant disease subgroups, to contribute to the development of marker-informed, risk-adapted therapy strategies in men with prostate cancer.
    Language English
    Publishing date 2024-04-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1225457-5
    ISSN 1557-3265 ; 1078-0432
    ISSN (online) 1557-3265
    ISSN 1078-0432
    DOI 10.1158/1078-0432.CCR-23-3740
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top